Advertisement

The Epidemiology of Uric Acid and Fructose

      Summary

      During the past few decades, the mean serum uric acid levels and the prevalence of hyperuricemia in the general population appear to have increased. Correspondingly, the prevalence and incidence of gout have doubled. Potential reasons behind these trends include the increasing prevalence of obesity and metabolic syndrome, Western lifestyle factors, increased prevalence of medical conditions (eg, renal conditions, hypertension, and cardiovascular disorders), and use of medications that increase uric acid levels (eg, diuretics and low-dose aspirin). The substantial increase in sugar-sweetened soft drinks and associated fructose consumption also has coincided with the secular trend of hyperuricemia and gout. Recently, several large-scale epidemiologic studies have clarified a number of these long-suspected risk factors in relation with hyperuricemia and gout. Furthermore, recent studies have illuminated the substantial comorbidities of hyperuricemia and gout, particularly metabolic-cardiovascular-renal conditions. Although many prospective studies have suggested an independent association between serum uric acid levels and the future risk of cardiovascular-metabolic morbidities and mortality, only a limited number of randomized clinical trials and observational studies recently have shown that the use of allopurinol can be beneficial against these outcomes. Because these data are scarce and the effects of allopurinol might not be limited to decreasing serum uric acid levels, the potential causal role of uric acid on these outcomes remains to be clarified with further studies.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Nephrology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Choi H.K.
        • Atkinson K.
        • Karlson E.W.
        • Willett W.
        • Curhan G.
        Purine-rich foods, dairy and protein intake, and the risk of gout in men.
        N Engl J Med. 2004; 350: 1093-1103
        • Roubenoff R.
        • Klag M.J.
        • Mead L.A.
        • Liang K.Y.
        • Seidler A.J.
        • Hochberg M.C.
        Incidence and risk factors for gout in white men.
        JAMA. 1991; 266: 3004-3007
        • Choi H.K.
        • Curhan G.
        Independent impact of gout on mortality and risk for coronary heart disease.
        Circulation. 2007; 116: 894-900
        • Choi H.K.
        • De Vera M.A.
        • Krishnan E.
        Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.
        Rheumatology (Oxford). 2008; 47: 1567-1570
        • Choi H.K.
        • Ford E.S.
        Prevalence of the metabolic syndrome in individuals with hyperuricemia.
        Am J Med. 2007; 120: 442-447
        • Choi H.K.
        • Ford E.S.
        Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels—the Third National Health and Nutrition Examination Survey.
        Rheumatology (Oxford). 2008; 47: 713-717
        • Choi H.K.
        • Ford E.S.
        • Li C.
        • Curhan G.
        Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey.
        Arthritis Rheum. 2007; 57: 109-115
        • Kim S.Y.
        • Guevara J.P.
        • Kim K.M.
        • Choi H.K.
        • Heitjan D.F.
        • Albert D.A.
        Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.
        Arthritis Care Res (Hoboken). 2010; 62: 170-180
        • Kim S.Y.
        • De Vera M.A.
        • Choi H.K.
        Gout and mortality.
        Clin Exp Rheumatol. 2008; 26 (Suppl 51:S115-9)
        • Brand F.N.
        • McGee D.L.
        • Kannel W.B.
        • Stokes 3rd, J.
        • Castelli W.P.
        Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study.
        Am J Epidemiol. 1985; 121: 11-18
        • Chang H.Y.
        • Pan W.H.
        • Yeh W.T.
        • Tsai K.S.
        Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96).
        J Rheumatol. 2001; 28: 1640-1646
        • Glynn R.J.
        • Campion E.W.
        • Silbert J.E.
        Trends in serum uric acid levels 1961-1980.
        Arthritis Rheum. 1983; 26: 87-93
        • Harris C.M.
        • Lloyd D.C.
        • Lewis J.
        The prevalence and prophylaxis of gout in England.
        J Clin Epidemiol. 1995; 48: 1153-1158
        • Lawrence R.C.
        • Felson D.T.
        • Helmick C.G.
        • Arnold L.M.
        • Choi H.
        • Deyo R.A.
        • et al.
        Estimates of the prevalence of arthritis and other rheumatic conditions in the United States.
        Arthritis Rheum. 2008; 58: 26-35
        • Mikuls T.R.
        • Farrar J.T.
        • Bilker W.B.
        • Fernandes S.
        • Schumacher Jr, H.R.
        • Saag K.G.
        Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.
        Ann Rheum Dis. 2005; 64: 267-272
        • Ogura T.
        • Matsuura K.
        • Matsumoto Y.
        • Mimura Y.
        • Kishida M.
        • Otsuka F.
        • et al.
        Recent trends of hyperuricemia and obesity in Japanese male adolescents, 1991 through 2002.
        Metabolism. 2004; 53: 448-453
        • Rathmann W.
        • Haastert B.
        • Icks A.
        • Giani G.
        • Roseman J.M.
        Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.
        Eur J Epidemiol. 2007; 22: 439-445
        • Roddy E.
        • Zhang W.
        • Doherty M.
        The changing epidemiology of gout.
        Nat Clin Pract Rheumatol. 2007; 3: 443-449
        • Wallace K.L.
        • Riedel A.A.
        • Joseph-Ridge N.
        • Wortmann R.
        Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population.
        J Rheumatol. 2004; 31: 1582-1587
        • Zeng Q.Y.
        • Chen R.
        • Darmawan J.
        • Xiao Z.Y.
        • Chen S.B.
        • Wigley R.
        • et al.
        Rheumatic diseases in China.
        Arthritis Res Ther. 2008; 10: R17
        • Zhu Y.
        • Pandva B.
        • Choi H.K.
        Increasing gout prevalence in the US over the last two decades: the National Health and Nutrition Examination Survey (NHANES).
        American College of Rheumatology, Atlanta2010 (ACR #2154)
        • Zhu Y.
        • Zhang Y.
        • Choi H.K.
        The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial.
        Rheumatology. 2010; 49: 2391-2399
        • Zhu Y.
        • Pandva B.
        • Choi H.K.
        Prevalence of hyperuricemia in the US general population: the National Health and Nutrition Examination Survey (NHANES) 1999-2008.
        American College of Rheumatology, Atlanta2010 (ACR #1363)
        • Bray G.A.
        • Nielsen S.J.
        • Popkin B.M.
        Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity.
        Am J Clin Nutr. 2004; 79: 537-543
        • Johnson R.J.
        • Segal M.S.
        • Sautin Y.
        • Nakagawa T.
        • Feig D.I.
        • Kang D.H.
        • et al.
        Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
        Am J Clin Nutr. 2007; 86: 899-906
        • Putnam J.J.
        • Allshouse J.E.
        Food consumption, prices and expenditures, 1970-97.
        (accessed 10/1/2010)
        • Zhang W.
        • Doherty M.
        • Bardin T.
        • Pascual E.
        • Barskova V.
        • Conaghan P.
        • et al.
        EULAR evidence based recommendations for gout.
        Ann Rheum Dis. 2006; 65: 1312-1324
        • Centers for Disease Control and Prevention
        NHANES-III 1988-94 reference manuals and reports (on CD-ROM).
        National Center for Health Statistics, Hyattsville, MD1996
        • Choi H.K.
        • Liu S.
        • Curhan G.
        Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey.
        Arthritis Rheum. 2005; 52: 283-289
        • Adams P.F.
        • Hardy A.M.
        Current estimates from the National Health Interview Survey, 1998.
        Vital Health Stat 10. 1989; 173: 1-250
        • Benson V.
        • Marano M.A.
        Current estimates from the National Health Interview Survey, 1992.
        Vital Health Stat 10. 1994; 189: 1-269
        • Adams P.F.
        • Hendershot G.E.
        • Marano M.A.
        Current estimates from the National Health Interview Survey, 1996.
        Vital Health Stat. 1999; 200: 1-203
        • Lennane G.A.
        • Rose B.S.
        • Isdale I.C.
        Gout in the Maori.
        Ann Rheum Dis. 1960; 19: 120-125
        • Prior I.A.
        • Rose B.S.
        Uric acid, gout and public health in the South Pacific.
        N Z Med J. 1966; 65: 295-300
        • Klemp P.
        • Stansfield S.A.
        • Castle B.
        • Robertson M.C.
        Gout is on the increase in New Zealand.
        Ann Rheum Dis. 1997; 56: 22-26
        • Arromdee E.
        • Michet C.J.
        • Crowson C.S.
        • O'Fallon W.M.
        • Gabriel S.E.
        Epidemiology of gout: is the incidence rising?.
        J Rheumatol. 2002; 29: 2403-2406
        • Cassim B.
        • Mody G.M.
        • Deenadayalu V.K.
        • Hammond M.G.
        Gout in black South Africans: a clinical and genetic study.
        Ann Rheum Dis. 1994; 53: 759-762
        • Bhole V.
        • de Vera M.
        • Rahman M.M.
        • Krishnan E.
        • Choi H.
        Epidemiology of gout in women: fifty-two-year followup of a prospective cohort.
        Arthritis Rheum. 2010; 62: 1069-1076
        • Nicholls A.
        • Snaith M.L.
        • Scott J.T.
        Effect of oestrogen therapy on plasma and urinary levels of uric acid.
        Br Med J. 1973; 1: 449-451
        • Sumino H.
        • Ichikawa S.
        • Kanda T.
        • Nakamura T.
        • Sakamaki T.
        Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia.
        Lancet. 1999; 354: 650
        • Simon J.A.
        • Lin F.
        • Vittinghoff E.
        • Bittner V.
        The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
        Ann Epidemiol. 2006; 16: 138-145
        • Hak A.E.
        • Choi H.K.
        Menopause, postmenopausal hormone use and serum uric acid levels in US women—the Third National Health and Nutrition Examination Survey.
        Arthritis Res Ther. 2008; 10: R116
        • Hak A.E.
        • Curhan G.C.
        • Grodstein F.
        • Choi H.K.
        Menopause, postmenopausal hormone use and risk of incident gout.
        Ann Rheum Dis. 2010; 69: 1305-1309
        • Mikkelsen W.M.
        • Dodge H.J.
        • Valkenburg H.
        The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan 1959-1960.
        Am J Med. 1965; 39: 242-251
        • O'Sullivan J.B.
        Gout in a New England town.
        Ann Rheum Dis. 1972; 31: 166-169
        • Culleton B.F.
        • Larson M.G.
        • Kannel W.B.
        • Levy D.
        Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.
        Ann Intern Med. 1999; 131: 7-13
        • Fang J.
        • Alderman M.H.
        Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992.
        JAMA. 2000; 283: 2404-2410
        • Hochberg M.C.
        • Thomas J.
        • Thomas D.J.
        • Mead L.
        • Levine D.M.
        • Klag M.J.
        Racial differences in the incidence of gout.
        Arthritis Rheum. 1995; 38: 628-632
        • Emmerson B.T.
        The management of gout.
        N Engl J Med. 1996; 334: 445-451
        • Fam A.G.
        Gout, diet, and the insulin resistance syndrome.
        J Rheumatol. 2002; 29: 1350-1355
        • Zollner N.
        Influence of various purines on uric acid metabolism.
        Bibl Nutr Dieta. 1973; 19: 34-43
        • Zollner N.
        • Griebsch A.
        Diet and gout.
        Adv Exp Med Biol. 1974; 41: 435-442
        • Clifford A.J.
        • Riumallo J.A.
        • Young V.R.
        • Scrimshaw N.S.
        Effect of oral purines on serum and urinary uric acid of normal, hyperuricemic and gouty humans.
        J Nutr. 1976; 106: 428-434
        • Clifford A.J.
        • Story D.L.
        Levels of purines in foods and their metabolic effects in rats.
        J Nutr. 1976; 106: 435-442
        • Garrel D.R.
        • Verdy M.
        • PetitClerc C.
        • Martin C.
        • Brule D.
        • Hamet P.
        Milk- and soy-protein ingestion: acute effect on serum uric acid concentration.
        Am J Clin Nutr. 1991; 53: 665-669
        • Loenen H.M.
        • Eshuis H.
        • Lowik M.R.
        • Schouten E.G.
        • Hulshof K.F.
        • Odink J.
        • et al.
        Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System).
        J Clin Epidemiol. 1990; 43: 1297-1303
        • Kagan A.
        • Harris B.R.
        • Winkelstein Jr, W.
        • Johnson K.G.
        • Kato H.
        • Syme S.L.
        • et al.
        Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics.
        J Chronic Dis. 1974; 27: 345-364
        • Torralba T.P.
        • Bayani-Sioson P.S.
        The Filipino and gout.
        Semin Arthritis Rheum. 1975; 4: 307-320
        • Choi H.K.
        • Curhan G.
        Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey.
        Arthritis Rheum. 2004; 51: 1023-1029
        • Choi H.K.
        • Atkinson K.
        • Karlson E.W.
        • Willett W.
        • Curhan G.
        Alcohol intake and risk of incident gout in men: a prospective study.
        Lancet. 2004; 363: 1277-1281
        • Campion E.W.
        • Glynn R.J.
        • DeLabry L.O.
        Asymptomatic hyperuricemia.
        Am J Med. 1987; 82: 421-426
        • Abbott R.D.
        • Brand F.N.
        • Kannel W.B.
        • Castelli W.P.
        Gout and coronary heart disease: the Framingham Study.
        J Clin Epidemiol. 1988; 41: 237-242
        • Choi H.K.
        • Atkinson K.
        • Karlson E.W.
        • Curhan G.
        Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.
        Arch Intern Med. 2005; 165: 742-748
        • Rathmann W.
        • Funkhouser E.
        • Dyer A.R.
        • Roseman J.M.
        Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study.
        Ann Epidemiol. 1998; 8: 250-261
        • Emmerson B.T.
        Alteration of urate metabolism by weight reduction.
        Aust N Z J Med. 1973; 3: 410-412
        • Sjostrom L.
        • Lindroos A.K.
        • Peltonen M.
        • Torgerson J.
        • Bouchard C.
        • Carlsson B.
        • et al.
        Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.
        N Engl J Med. 2004; 351: 2683-2693
        • Choi H.K.
        • Curhan G.
        Coffee consumption and risk of incident gout in women: the Nurses' Health Study.
        Am J Clin Nutr. 2010; 92: 922-927
        • Choi H.K.
        • Willett W.
        • Curhan G.
        Coffee consumption and risk of incident gout in men: a prospective study.
        Arthritis Rheum. 2007; 56 (2049–55)
        • Kela U.
        • Vijayvargiya R.
        • Trivedi C.P.
        Inhibitory effects of methylxanthines on the activity of xanthine oxidase.
        Life Sci. 1980; 27: 2109-2119
        • Petrie H.J.
        • Chown S.E.
        • Belfie L.M.
        • Duncan A.M.
        • McLaren D.H.
        • Conquer J.A.
        • et al.
        Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss.
        Am J Clin Nutr. 2004; 80: 22-28
        • van Dam R.M.
        • Hu F.B.
        Coffee consumption and risk of type 2 diabetes: a systematic review.
        JAMA. 2005; 294: 97-104
        • Wu T.
        • Willett W.C.
        • Hankinson S.E.
        • Giovannucci E.
        Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women.
        Diabetes Care. 2005; 28: 1390-1396
        • Arnlov J.
        • Vessby B.
        • Riserus U.
        Coffee consumption and insulin sensitivity.
        JAMA. 2004; 291: 1199-1201
        • Choi H.K.
        • Curhan G.
        Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey.
        Arthritis Rheum. 2007; 57: 816-821
        • Pham N.M.
        • Yoshida D.
        • Morita M.
        • Yin G.
        • Toyomura K.
        • Ohnaka K.
        • et al.
        The relation of coffee consumption to serum uric acid in Japanese men and women aged 49-76 years.
        J Nutr Metab. 2010; 2010 (pii 930757)
        • Kiyohara C.
        • Kono S.
        • Honjo S.
        • Todoroki I.
        • Sakurai Y.
        • Nishiwaki M.
        • et al.
        Inverse association between coffee drinking and serum uric acid concentrations in middle-aged Japanese males.
        Br J Nutr. 1999; 82: 125-130
        • Berger L.
        • Gerson C.D.
        • Yu T.F.
        The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid.
        Am J Med. 1977; 62: 71-76
        • Sutton J.L.
        • Basu T.K.
        • Dickerson J.W.
        Effect of large doses of ascorbic acid in man on some nitrogenous components of urine.
        Hum Nutr Appl Nutr. 1983; 37: 136-140
        • Stein H.B.
        • Hasan A.
        • Fox I.H.
        Ascorbic acid-induced uricosuria.
        Ann Intern Med. 1976; 84: 385-388
        • Choi H.K.
        • Gao X.
        • Curhan G.
        Vitamin C intake and the risk of gout in men: a prospective study.
        Arch Intern Med. 2009; 169: 502-507
        • Mitch W.E.
        • Johnson M.W.
        • Kirshenbaum J.M.
        • Lopez R.E.
        Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects.
        Clin Pharmacol Ther. 1981; 29: 318-321
        • Huang H.Y.
        • Appel L.J.
        • Choi M.J.
        • Gelber A.C.
        • Charleston J.
        • Norkus E.P.
        • et al.
        The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial.
        Arthritis Rheum. 2005; 52 (1843–7)
        • Lyu L.C.
        • Hsu C.Y.
        • Yeh C.Y.
        • Lee M.S.
        • Huang S.H.
        • Chen C.L.
        A case-control study of the association of diet and obesity with gout in Taiwan.
        Am J Clin Nutr. 2003; 78: 690-701
        • Gao X.
        • Curhan G.
        • Forman J.P.
        • Ascherio A.
        • Choi H.K.
        Vitamin C intake and serum uric acid concentration in men.
        J Rheumatol. 2008; 35: 1853-1858
        • Choi H.K.
        • Mount D.B.
        • Reginato A.M.
        Pathogenesis of gout.
        Ann Intern Med. 2005; 143: 499-516
        • White J.S.
        Straight talk about high-fructose corn syrup: what it is and what it ain't.
        Am J Clin Nutr. 2008; 88: 1716S-1721S
        • Murray R.
        • Frankowski B.
        • Taras H.
        Are soft drinks a scapegoat for childhood obesity?.
        J Pediatr. 2005; 146: 586-590
        • Ralston K.
        • Lin B.H.
        Food assistance research brief—competitive foods: soft drinks vs. milk. Food assistance and nutrition research report no (FANRR34-7). [cited 2010 October 1].
        • Clauson A.
        How Americans quench their thirsts. [cited 2010 October 1].
        • Schulze M.B.
        • Manson J.E.
        • Ludwig D.S.
        • Colditz G.A.
        • Stampfer M.J.
        • Willett W.C.
        • et al.
        Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women.
        JAMA. 2004; 292: 927-934
        • Apovian C.M.
        Sugar-sweetened soft drinks, obesity, and type 2 diabetes.
        JAMA. 2004; 292: 978-979
        • Choi H.K.
        • Curhan G.
        Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.
        BMJ. 2008; 336: 309-312
        • Gibson T.
        • Rodgers A.V.
        • Simmonds H.A.
        • Court-Brown F.
        • Todd E.
        • Meilton V.
        A controlled study of diet in patients with gout.
        Ann Rheum Dis. 1983; 42: 123-127
        • Fox I.H.
        • Kelley W.N.
        Studies on the mechanism of fructose-induced hyperuricemia in man.
        Metab Clin Exp. 1972; 21: 713-721
        • Choi J.W.
        • Ford E.S.
        • Gao X.
        • Choi H.K.
        Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey.
        Arthritis Rheum. 2008; 59: 109-116
        • Beck-Nielsen H.
        • Pedersen O.
        • Lindskov H.O.
        Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects.
        Am J Clin Nutr. 1980; 33: 273-278
        • Thorburn A.W.
        • Storlien L.H.
        • Jenkins A.B.
        • Khouri S.
        • Kraegen E.W.
        Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats.
        Am J Clin Nutr. 1989; 49: 1155-1163
        • Dhingra R.
        • Sullivan L.
        • Jacques P.F.
        • Wang T.J.
        • Fox C.S.
        • Meigs J.B.
        • et al.
        Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community.
        Circulation. 2007; 116: 480-488
        • Ludwig D.S.
        • Peterson K.E.
        • Gortmaker S.L.
        Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis.
        Lancet. 2001; 357: 505-508
        • Malik V.S.
        • Popkin B.M.
        • Bray G.A.
        • Despres J.P.
        • Willett W.C.
        • Hu F.B.
        Sugar sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis.
        Diabetes Care. 2010; 33: 2477-2483
        • Elliott S.S.
        • Keim N.L.
        • Stern J.S.
        • Teff K.
        • Havel P.J.
        Fructose, weight gain, and the insulin resistance syndrome.
        Am J Clin Nutr. 2002; 76: 911-922
        • Nguyen S.
        • Choi H.K.
        • Lustig R.H.
        • Hsu C.Y.
        Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents.
        J Pediatr. 2009; 154: 807-813
        • Jalal D.I.
        • Smits G.
        • Johnson R.J.
        • Chonchol M.
        Increased fructose associates with elevated blood pressure.
        J Am Soc Nephrol. 2010; 21: 1543-1549
        • Forman J.P.
        • Choi H.
        • Curhan G.C.
        Fructose and vitamin C intake do not influence risk for developing hypertension.
        J Am Soc Nephrol. 2009; 20: 863-871
        • Shoham D.A.
        • Durazo-Arvizu R.
        • Kramer H.
        • Luke A.
        • Vupputuri S.
        • Kshirsagar A.
        • et al.
        Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004.
        PLoS One. 2008; 3: e3431
        • Bomback A.S.
        • Derebail V.K.
        • Shoham D.A.
        • Anderson C.A.
        • Steffen L.M.
        • Rosamond W.D.
        • et al.
        Sugar-sweetened soda consumption, hyperuricemia, and kidney disease.
        Kidney Int. 2010; 77: 609-616
        • Ford E.S.
        • Giles W.H.
        • Dietz W.H.
        Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.
        JAMA. 2002; 287: 356-359
        • Ford E.S.
        Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.
        Diabetes Care. 2005; 28: 1769-1778
        • Enomoto A.
        • Kimura H.
        • Chairoungdua A.
        • Shigeta Y.
        • Jutabha P.
        • Cha S.H.
        • et al.
        Molecular identification of a renal urate anion exchanger that regulates blood urate levels.
        Nature. 2002; 417: 447-452
        • Facchini F.
        • Chen Y.D.
        • Hollenbeck C.B.
        • Reaven G.M.
        Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.
        JAMA. 1991; 266: 3008-3011
        • Muscelli E.
        • Natali A.
        • Bianchi S.
        • Bigazzi R.
        • Galvan A.Q.
        • Sironi A.M.
        • et al.
        Effect of insulin on renal sodium and uric acid handling in essential hypertension.
        Am J Hypertens. 1996; 9: 746-752
        • Ter Maaten J.C.
        • Voorburg A.
        • Heine R.J.
        • Ter Wee P.M.
        • Donker A.J.
        • Gans R.O.
        Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects.
        Clin Sci (Lond). 1997; 92: 51-58
        • Lee J.
        • Sparrow D.
        • Vokonas P.S.
        • Landsberg L.
        • Weiss S.T.
        Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome.
        Am J Epidemiol. 1995; 142: 288-294
        • Emmerson B.
        Hyperlipidaemia in hyperuricaemia and gout.
        Ann Rheum Dis. 1998; 57: 509-510
        • Snaith M.L.
        Gout: diet and uric acid revisited.
        Lancet. 2001; 358: 525
        • Bhole V.
        • Choi J.W.
        • Kim S.W.
        • De Vera M.
        • Choi H.
        Serum uric acid levels and the risk of type 2 diabetes: a prospective study.
        Am J Med. 2010; 123: 957-961
        • Dehghan A.
        • van Hoek M.
        • Sijbrands E.J.
        • Hofman A.
        • Witteman J.C.
        High serum uric acid as a novel risk factor for type 2 diabetes.
        Diabetes Care. 2008; 31: 361-362
        • Kramer C.K.
        • von Muhlen D.
        • Jassal S.K.
        • Barrett-Connor E.
        Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study.
        Diabetes Care. 2009; 32: 1272-1273
        • Niskanen L.
        • Laaksonen D.E.
        • Lindstrom J.
        • Eriksson J.G.
        • Keinanen-Kiukaanniemi S.
        • Ilanne-Parikka P.
        • et al.
        Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study.
        Diabetes Care. 2006; 29: 709-711
        • Grayson P.C.
        • Kim S.Y.
        • Lavalley M.
        • Choi H.K.
        Hyperuricemia and incident hypertension: a systematic review and meta-analysis.
        Arthritis Care Res. 2011; 63: 102-110
        • Kim S.Y.
        • Guevara J.P.
        • Kim K.M.
        • Choi H.K.
        • Heitjan D.F.
        • Albert D.A.
        Hyperuricemia and risk of stroke: a systematic review and meta-analysis.
        Arthritis Rheum. 2009; 61: 885-892
        • Hsu C.Y.
        • Iribarren C.
        • McCulloch C.E.
        • Darbinian J.
        • Go A.S.
        Risk factors for end-stage renal disease: 25-year follow-up.
        Arch Intern Med. 2009; 169: 342-350
        • Johnson R.J.
        • Kang D.H.
        • Feig D.
        • Kivlighn S.
        • Kanellis J.
        • Watanabe S.
        • et al.
        Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.
        Hypertension. 2003; 41: 1183-1190
        • Noman A.
        • Ang D.S.
        • Ogston S.
        • Lang C.C.
        • Struthers A.D.
        Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial.
        Lancet. 2010; 375: 2161-2167
        • Thanassoulis G.
        • Brophy J.M.
        • Richard H.
        • Pilote L.
        Gout, allopurinol use, and heart failure outcomes.
        Arch Intern Med. 2010; 170: 1358-1364
        • Luk A.J.
        • Levin G.P.
        • Moore E.E.
        • Zhou X.H.
        • Kestenbaum B.R.
        • Choi H.K.
        Allopurinol and mortality in hyperuricaemic patients.
        Rheumatology (Oxford). 2009; 48: 804-806
        • Siu Y.P.
        • Leung K.T.
        • Tong M.K.
        • Kwan T.H.
        Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
        Am J Kidney Dis. 2006; 47: 51-59
        • Curhan G.C.
        • Forman J.P.
        Sugar-sweetened beverages and chronic disease.
        Kidney Int. 2010; 77: 569-570
        • Currie W.J.
        Prevalence and incidence of the diagnosis of gout in Great Britain.
        Ann Rheum Dis. 1979; 38: 101-106
        • Williams P.T.
        Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men.
        Am J Clin Nutr. 2008; 87: 1480-1487
        • Gao X.
        • Qi L.
        • Qiao N.
        • Choi H.K.
        • Curhan G.
        • Tucker K.L.
        • et al.
        Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women.
        Hypertension. 2007; 50: 306-312
        • Choi H.K.
        A prescription for lifestyle change in patients with hyperuricemia and gout.
        Curr Opin Rheumatol. 2010; 22: 165-172
        • Wilder M.H.
        Prevalence of chronic skin and musculoskeletal conditions, United States, 1969.
        Vital Health Stat. 1974; 10: 92
        • Bonham G.S.
        Prevalence of chronic skin and musculoskeletal conditions, United States, 1976.
        Vital Health Stat. 1981; 10: 124
        • Dawson D.A.
        • Adams P.F.
        Current estimates From the National Health Interview Survey, United States, 1986.
        Vital Health Stat. 1987; 10: 164